ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 732336 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 732336; 2) Community: the network communities that were significantly associated with the response to NSC 732336; 3) Molecule: the relationships between components within communities and NSC 732336; 4) MDR: the compounds that were significantly associated with the NSC 732336.

NSC Compound Enrichment Correlation
NSC 163424 4-Quinazolinamine, 2-[2-(1-pyrrolidinylazo)phenyl]- 0.0238174255956147 0.47968301
NSC 3077 s-Triazine, 4,6-diamino-1-(3,4-dichlorophenyl)-1,2-dihydro-2,2-dimethyl-, monohydrochloride (8CI) 0.0238174255956147 0.17025117
NSC 30915 Null 0.0238174255956147 0.2590134
NSC 33570 Null 0.0238174255956147 0.41560549
NSC 339579 7H-Pyrrolo[3,2-f]quinazoline-2,4-diamine, 7-[(3-nitrophenyl)methyl]-, monoacetate 0.0238174255956147 0.40486126
NSC 354974 Acetamide, N-(5,6,7,9-tetrahydro-2,3-dihydroxy-1,10-dimethoxy-9-oxobenzo[a]heptalen-7-yl)-, (S)- 0.0238174255956147 -0.15612977
NSC 359239 Antibiotic X-14766A 0.0238174255956147 -0.24678808
NSC 363813 Platinum, tetrachloro(1,2-cyclohexanediamine-N,N')-, [OC-6-22-(1S-trans)]- 0.0238174255956147 0.29218532
NSC 606497 Camptothecin Derivative 0.0238174255956147 0.16194204
NSC 629229 Null 0.0238174255956147 0.18742334
Total:85  Current:38    [First] [Prev] [Next] [Last]